Harnessing GMNP-loaded BMSC-derived EVs to target miR-3064-5p via MEG3 overexpression: Implications for diabetic osteoporosis therapy in rats
In conclusion, GMNPs loaded with BMSC-EVs, through the delivery of MEG3 targeting miR-3064-5p, can effectively promote NR4A3 expression, activate the PINK1/Parkin pathway, and thereby enhance osteoblast proliferation and differentiation, offering a promising treatment for DO.PMID:38246512 | DOI:10.1016/j.cellsig.2024.111055
Source: Cellular Signalling - Category: Cytology Authors: Chen Xu Zhaodong Wang Ya Jun Liu Keyou Duan Jianzhong Guan Source Type: research
More News: Cytology | Diabetes | Endocrinology | Nanotechnology | Orthopaedics | Osteoporosis | Stem Cell Therapy | Stem Cells | Study